Sprouty: how does the branch manager work?
- PMID: 12829736
- DOI: 10.1242/jcs.00652
Sprouty: how does the branch manager work?
Abstract
Since the discovery of the prototypical Sprouty (Spry) protein in Drosophila, there has been an effort to determine how these novel modulators of the Ras/MAP-kinase pathway function. A clue to their mechanism of action comes from the several highly conserved sequences within all the currently known Spry isoforms: an approximately 110-residue cysteine-rich sequence in the C-terminal half that directs Spry proteins to a concentration of signaling proteins at the plasma membrane; a small motif surrounding a tyrosine residue (Y55 in human Spry2) that is responsible for interaction with other proteins. In cultured mammalian cells, hSpry2 inhibits epidermal growth factor receptor (EGFR) endocytosis and subsequently sustains the activation of MAP kinase but negatively regulates the same pathway following stimulation of fibroblast growth factor receptors (FGFRs). Current evidence indicates that Cbl is a key protein that interacts directly with Spry2 following activation of receptor tyrosine kinases (RTKs). It appears to be the ability of Cbl to interact as an E3 ubiquitin ligase on specific target proteins and as a docking protein in other contexts that dictates the differential effects Spry2 has on the Ras/MAP-kinase pathway following EGFR and FGFR activation.
Similar articles
-
Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.Nat Cell Biol. 2002 Nov;4(11):850-8. doi: 10.1038/ncb867. Nat Cell Biol. 2002. PMID: 12402043
-
EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.Biol Chem. 2003 Aug;384(8):1215-26. doi: 10.1515/BC.2003.134. Biol Chem. 2003. PMID: 12974390
-
Sprouty proteins, masterminds of receptor tyrosine kinase signaling.Angiogenesis. 2008;11(1):53-62. doi: 10.1007/s10456-008-9089-1. Epub 2008 Jan 25. Angiogenesis. 2008. PMID: 18219583 Review.
-
FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity.J Cell Sci. 2004 Dec 1;117(Pt 25):6007-17. doi: 10.1242/jcs.01519. J Cell Sci. 2004. PMID: 15564375
-
Sprouty proteins: modified modulators, matchmakers or missing links?J Endocrinol. 2009 Nov;203(2):191-202. doi: 10.1677/JOE-09-0110. Epub 2009 May 7. J Endocrinol. 2009. PMID: 19423641 Review.
Cited by
-
SPRY4 promotes adipogenic differentiation of human mesenchymal stem cells through the MEK-ERK1/2 signaling pathway.Adipocyte. 2022 Dec;11(1):588-600. doi: 10.1080/21623945.2022.2123097. Adipocyte. 2022. PMID: 36082406 Free PMC article.
-
Overexpression of sprouty 1 protein in human oral squamous cell carcinogenesis.J Dent Sci. 2021 Jan;16(1):21-28. doi: 10.1016/j.jds.2020.07.013. Epub 2020 Aug 18. J Dent Sci. 2021. PMID: 33384774 Free PMC article.
-
Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle.EBioMedicine. 2019 Dec;50:166-177. doi: 10.1016/j.ebiom.2019.11.021. Epub 2019 Nov 22. EBioMedicine. 2019. PMID: 31761616 Free PMC article.
-
Lack of Sprouty 1 and 2 enhances survival of effector CD8+ T cells and yields more protective memory cells.Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8939-E8947. doi: 10.1073/pnas.1808320115. Epub 2018 Aug 20. Proc Natl Acad Sci U S A. 2018. PMID: 30126987 Free PMC article.
-
Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.Blood. 2016 May 12;127(19):2310-21. doi: 10.1182/blood-2015-09-669317. Epub 2016 Jan 25. Blood. 2016. PMID: 26809508 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous